Skip to content

Exploring the impact of aging and inflammation on neurocognitive changes in people with Long COVID (NC-LC)

Aging | Inflammation | Neurocognitive Impairment | COVID-19 | Long COVID | Post-COVID Syndrome

COVID-19 has had a significant impact on the lives of many Albertans. Neurological deficits are an increasingly recognized complication of COVID-19, caused by the coronavirus, SARS-CoV-2. Among COVID-19 survivors, 10-30% develop persistent multi-system symptoms termed Long COVID. Neurocognitive impairments are commonly (>25%) reported in Long COVID, together with pain, fatigue and sleep disorders. Thus, the purpose of this study is to investigate if there are inflammatory causes of these neurocognitive symptoms as well as what is the prevalence, risk factors, and predictors of neurocognitive impairments among people with long COVID

null

Participation Requirements

  • Sex:

    Any

  • Eligible Ages:

    18 and up

Participation Criteria

Inclusion Criteria:
Any adult individuals (aged 18 and up) who have recovered from acute COVID-19 (as confirmed by a COVID-19 test) and experiencing persistent symptoms of at least 12 weeks are invited to participate in this study. As well, anyone who has never been infected with COVID-19 is invited to participate as well to serve as a matched comparison group to those who are suffering from long COVID.
Exclusion Criteria:
Exclusion criteria are neurocognitive impairments prior to developing COVID-19, absent English language proficiency, less than Grade 9 education, and ongoing illicit substance use (as this can bias the testing results).

Study Location

University of Alberta
University of Alberta
Edmonton, Alberta
Canada

Contact Study Team

Primary Contact

Karina Kaur

[email protected]
null
Study Sponsored By
University of Alberta
Participants Required
More Information
Study ID: Pro00118528